WithdrawnNot Applicable

Study to Evaluate the Effectiveness and Safety of Libicare® in Women With Low Arousal and Sexual Desire Levels

Stopped: Sponsor decision

Spain0Started 2019-11-14

Plain-language summary

The purpose of this study is to evaluate the effectiveness of Libicare® in the sexual desire and arousal at 12 weeks in peri or postmenopausal women aged between 40 and 60 years old with low sexual desire and arousal compared with active control.

Who can participate

Age range45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Female aged between 40 and 60 years old.
✓. Healthy peri or postmenopausal women.
✓. Body Mass Index (BMI) between 18,5-29,9.
✓. Female with low sexual desire and low arousal with a score ≤26.55 on the questionnaire Female Sexual Function Index (FSFI) .
✓. Patients who signed the Informed Consent Form.

Exclusion criteria

✕. Female with uncontrolled thyroid function.
✕. Female with severe genital pain (vaginism, stopping intercourse because of severe pain).
✕. Female diagnosed with primary female orgasmic disorder.
✕. No coital intercourse a month.
✕. Lack of steady sexual partner.
✕. Suffering from any serious medical condition (any disease which may force the participant to use drug during the study).
✕. Suffering from major depression disorder or other psychiatric disorders.
✕. Women on anticoagulant treatment.

What they're measuring

Evolution of sexual desire and arousal

Timeframe: 12 weeks

Trial details

NCT IDNCT04188600

SponsorProcare Health Iberia S.L.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2023-11-30

View on ClinicalTrials.gov More Female Sexual Interest/Arousal Disorder trials